Emcure Pharmaceuticals Limited — Tenofovir Exporter Profile
Indian Pharmaceutical Exporter · #5 for Tenofovir · $14.3M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #5 Indian exporter of Tenofovir with $14.3M in export value and 279 verified shipments. Emcure Pharmaceuticals Limited holds a 0.3% market share in Tenofovir exports across 45 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Tenofovir Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Tenofovir?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $3.1M | 63 | 28.8% |
| MYANMAR | $1.7M | 41 | 16.2% |
| KENYA | $1.4M | 32 | 13.3% |
| ZIMBABWE | $1.1M | 22 | 10.3% |
| PAKISTAN | $450.0K | 9 | 4.2% |
| CONGO D REPULIC | $300.0K | 6 | 2.8% |
| LESOTHO | $293.7K | 6 | 2.7% |
| DOMINICAN REPULIC | $275.6K | 7 | 2.6% |
| EGYPT | $272.7K | 7 | 2.5% |
| VENEZUELA | $200.0K | 4 | 1.9% |
Emcure Pharmaceuticals Limited exports Tenofovir to 49 countries. The largest destination is SOUTH AFRICA accounting for 28.8% of Emcure Pharmaceuticals Limited's Tenofovir shipments, followed by MYANMAR (16.2%) and KENYA (13.3%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tenofovir from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| EMCURE PHARMACEUTICALS SA (PTY) LTD | SOUTH AFRICA | $2.5M | 51 |
| UNITED NATIONS OFFICE FOR PROJECT | MYANMAR | $1.4M | 31 |
| MINISTRY OF HEALTH AND CHILD CARE | ZIMBABWE | $1.1M | 22 |
| UNITED NATIONS DEVELOPMENT PROGRAMM | PAKISTAN | $1.0M | 21 |
| SYNERMEDICA KENYA LIMITED | KENYA | $900.0K | 18 |
| EMCURE PHARMACEUTICALS SA PTY LTD | SOUTH AFRICA | $350.0K | 7 |
| UNITED NATIONS OFFICE FOR PROJECT S | MYANMAR | $300.0K | 6 |
| NATIONAL DRUGS SERVICE ORGANISATION | LESOTHO | $293.7K | 6 |
| UNDP EGYPT CO | EGYPT | $272.7K | 7 |
| KENYA MEDICAL SUPPLIES AUTHORITY COMMERCIAL STREET INDUSTRIAL AREA | KENYA | $250.0K | 5 |
Emcure Pharmaceuticals Limited supplies Tenofovir to 67 buyers globally. The largest buyer is EMCURE PHARMACEUTICALS SA (PTY) LTD (SOUTH AFRICA), followed by UNITED NATIONS OFFICE FOR PROJECT (MYANMAR) and MINISTRY OF HEALTH AND CHILD CARE (ZIMBABWE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tenofovir Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $227.1M worth of Tenofovir through 7,518 shipments from 296 suppliers to 182 countries, serving 1,436 buyers globally. Emcure Pharmaceuticals Limited contributes $14.3M to this total, accounting for 0.3% of India's Tenofovir exports. Emcure Pharmaceuticals Limited ships Tenofovir to 49 countries through 67 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Tenofovir Exports?
Emcure Pharmaceuticals Limited's average Tenofovir shipment value is $51.3K per consignment, based on 279 shipments totaling $14.3M. The largest destination is SOUTH AFRICA (28.8% of Emcure Pharmaceuticals Limited's Tenofovir exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Tenofovir Exporters?
Emcure Pharmaceuticals Limited ranks #5 among 296 Indian Tenofovir exporters with a 0.3% market share. The top 3 exporters are HETERO LABS LIMITED ($64.3M), MYLAN LABORATORIES LIMITED ($50.1M), CIPLA LIMITED ($40.4M). Emcure Pharmaceuticals Limited processed 279 shipments to 45 destination countries.
What Tenofovir Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICALS PRODUCTS ( FINISHED PRODUCT) : LAVEM 50/300/300 MG TABLET 84S (DOLUTEGRAVIR, LAMIVUDINE , TENOFOVIR DI | $650.0K | 13 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - SIROPIL 50/300/300MG TABLET 90S WTC ( DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR | $650.0K | 13 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS)- VIROPIL 50/300/300MG TABLET 90S WTC (DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR DINOS | $600.0K | 12 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS): - SIROPIL 50/300/300MG TABLET 30S WTC ( DOLUTEGRAVIR, LAMIVUDINE , TENOFOVIR | $543.7K | 11 |
| PHARMA PROD(FINISHED PROD) LAVEM 50/300/300 MG TABLET 90S WTC(DOLUTEGRAVIR,LAMIVUDINE,TENOFOVIR DISOPROXIL FUMARATE TAB. | $450.0K | 9 |
| PHARMACEUTICALS PRODUCTS ( FINISHED PRODUCT) : LAVEM 50/300/300 MG TABLET 84S ,( DOLUTEGRAVIR, LAMIVUDINE , TENOFOVIR D | $450.0K | 9 |
| PHARMACEUTICAL PRODUCTS (FINISHED GOODS)- VIROPIL 50/300/300MG TABLET 90S WTC (DOLUTEGRAVIR, LAMIVUDINE & TENOFOVIR DI | $400.0K | 8 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM FINISHED GOODS- VIROPIL 50/300/300MG TABLET 90S DOLUTEGRAVIR LAMIVUDINE & TENOFOVIR DISOPR | $350.0K | 7 |
| PHARMACEUTICAL PRODUCTS FINISHED GOODS VIROPIL 50 300 300MG TABLET 90S DOLUTEGRAVIR LAMIVUDINE TENOFOVIR DISOPR | $250.0K | 5 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM FINISHED GOODS- TAVIN EM 300/200MG TABLET 30S TENOFOVIR DISOPROXIL FUMARATE & EMTRICITABIN | $250.0K | 5 |
Emcure Pharmaceuticals Limited exports 135 distinct Tenofovir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICALS PRODUCTS ( FINISHED PRODUCT) : LAVEM 50/300 with 13 shipments worth $650.0K.
Regulatory Requirements: Exporting Tenofovir to Key Markets
What Emcure Pharmaceuticals Limited must comply with to export Tenofovir to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Tenofovir Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | CIPLA LIMITED | $40.4M | 808 | 44 | $50.0K |
| 1 | MACLEODS PHARMACEUTICALS LTD | $25.9M | 519 | 74 | $50.0K |
| 5 | EMCURE PHARMACEUTICALS LIMITED ★ | $13.9M | 279 | 45 | $50.0K |
| 7 | MACLEODS PHARMACEUTICALS LIMITED | $11.4M | 228 | 43 | $50.0K |
| 10 | AUROBINDO PHARMA LTD | $6.8M | 137 | 10 | $50.0K |
Emcure Pharmaceuticals Limited ranks #5 among 296 Indian Tenofovir exporters. Average shipment value of $50.0K compared to the market average of $767.2K. The closest competitors by value are CIPLA LIMITED and MACLEODS PHARMACEUTICALS LTD.
Which Indian Ports Ship Tenofovir Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,351 | 18.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,121 | 14.9% |
| NHAVA SHEVA SEA (INNSA1) | 526 | 7.0% |
| DELHI AIR CARGO ACC (INDEL4) | 463 | 6.2% |
| HYDERABAD AIR | 453 | 6.0% |
| DELHI AIR | 433 | 5.8% |
| Bombay Air | 371 | 4.9% |
| HYDERABAD ACC (INHYD4) | 351 | 4.7% |
What Other Antiviral & HIV Medications Products Does Emcure Pharmaceuticals Limited Export?
Emcure Pharmaceuticals Limited also exports these antiviral & hiv medications products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Tenofovir Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Tenofovir, top products include Dolutegravir, Mycophenolate, Iron, Melphalan, Atazanavir. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tenofovir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tenofovir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 286 individual customs records matching Emcure Pharmaceuticals Limited exporting Tenofovir, covering 135 formulations to 49 countries via 67 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 182+ countries, 1,436+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tenofovir Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Tenofovir exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Tenofovir Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tenofovir. For current shipment-level data, contact TransData Nexus.